Table 1 Univariate analysis of TCGA-LIHC patient overall survival and progression-free survival

Age

1.070

0.717–1.597

0.741

0.909

0.645–1.281

0.585

Gender

0.750

0.511–1.100

0.14

0.957

0.674–1.36

0.808

HBV

0.470

0.280–0.791

0.004

0.734

0.498–1.082

0.118

HCV

1.134

0.590–2.179

0.707

1.703

1.048–2.766

0.032

Etiology

1.442

0.693–1.821

0.002

1.035

0.846–1.265

0.74

AJCC_T

2.369

1.617–3.471

0.000

2.242

1.582–3.178

0.000

Stage

2.348

1.605–3.436

0.000

2.257

1.598–3.188

0.000

RCL1

0.607

0.416–0.886

0.009

0.661

0.476–0.917

0.01